SCHEMBL22383271

SCHEMBL22383271

CCN(CCC(=O)NCCN(CCC(=O)O)CCC(=O)O)CCC(=O)NCCN(CCC(=O)O)CCC(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.44
DNM1 Q05193 2/20 0.42
KDM5A P29375 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP3A4 P08684 1/20 0.40
ALDH1A1 P00352 4/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 2/20 0.38
SLC22A2 O15244 1/20 0.38
SLC22A1 O15245 1/20 0.38
TSHR P16473 1/20 0.38
ACHE P22303 1/20 0.38
MAPK1 P28482 1/20 0.38
CYP2C19 P33261 1/20 0.38
EPHX2 P34913 2/20 0.37
BLM P54132 1/20 0.37
PMP22 Q01453 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10082396 0.89 CASP2 (0.48) DNM1KDM5AKMT2AMEN1EPHX2
SCHEMBL24626058 0.89 CYP1A2 (0.46) GAADNM1CYP1A2CYP2D6CYP3A4
SCHEMBL17762997 0.88 ECE1 (0.42) GAADNM1LMNATSHRCYP2C19
SCHEMBL93812 0.87 GAA (0.49) GAADNM1CYP1A2CYP2D6CYP3A4
SCHEMBL10005311 0.86 DNM1 (0.40) GAADNM1CYP1A2CYP2D6CYP3A4
SCHEMBL10066553 0.85 ADRA1A (0.48) GAADNM1ALDH1A1TSHRMAPK1
SCHEMBL22383272 0.85 DNM1 (0.42) GAADNM1KDM5AKDM4CKMT2A
Hydrochloric Acid SCHEMBL93987 0.85 GAA (0.48) GAADNM1CYP1A2CYP2D6CYP3A4
SCHEMBL24626480 0.85 GAA (0.51) GAADNM1CYP1A2CYP2D6CYP3A4
SCHEMBL24626074 0.85 GAA (0.51) GAADNM1CYP1A2CYP2D6CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10759824-B2 Design, synthesis and use of synthetic nucleotides comprising charge mass tags QUANTUMDX GROUP LIMITED (GB) 2020-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10759824-B2 Design, synthesis and use of synthetic nucleotides comprising charge mass tags POLM, RNGTT, TYMP GAA 522/4885DNM1 1344/4885KDM5A 2126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.